The effect of heparin on trinitrobenzene sulphonic acid‐induced colitis in the rat
- 1 March 1998
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 12 (3) , 229-236
- https://doi.org/10.1046/j.1365-2036.1998.00293.x
Abstract
Background: Reduced blood coagulability seems to protect against inflammatory bowel disease; pilot studies using heparin in patients with inflammatory bowel disease have reported positive results. Aim: To evaluate the effects of heparin treatment on microangiographic and on inflammatory parameters in experimental colitis, induced by trinitrobenzene sulphonic acid (TNBS)‐ethanol. Methods: Four groups of rats: (i) controls (saline enema), TNBS‐induced colitis with (ii) sham treatment (saline, s.c.), (iii) dexamethasone (0.25 mg/kg/day s.c.) and (iv) heparin (500 U/kg t.d.s., s.c.). Microangiography was performed 2 and 4 days after colitis induction. Partial thromboplastin time, colonic wet weight, macroscopic damage score and mucosal myeloperoxidase (MPO) activity were determined at day 4. Results: TNBS‐induced colitis caused a reduction in visible bowel wall vessels, which was prevented by heparin (P < 0.05) but not by steroids. The macroscopic damage scores and colon wet weights were similar in all colitis groups. Compared to untreated colitis the MPO activity in heparin‐treated animals was of borderline significance. Conclusions: Heparin treatment improved microangiographic features and reduced inflammation to a certain degree. Steroids delayed development of colon hypoperfusion, but were ineffective on MPO activity. It remains to be determined if the observed effects are due to the antithrombotic activity of heparin or to an anti‐inflammatory action.Keywords
This publication has 24 references indexed in Scilit:
- Is nitric oxide and heparin treatment justified in inflammatory bowel disease? An experimental studyScandinavian Journal of Clinical and Laboratory Investigation, 1996
- Therapeutic uses of heparin beyond its traditional role as an anticoagulantTrends in Pharmacological Sciences, 1995
- Inherited disorders of coagulation appear to protect against inflammatory bowel diseaseGastroenterology, 1995
- Platelet dysfunction: a new dimension in inflammatory bowel disease.Gut, 1995
- Dexamethasone promotes ulcer plugging in experimental enteritisAlimentary Pharmacology & Therapeutics, 1994
- Heparin has an inhibitory effect on endothelin-1 synthesis and release by endothelial cells.Hypertension, 1993
- Mucosal capillary thrombi in rectal biopsiesHistopathology, 1992
- On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin.Journal of Clinical Investigation, 1991
- High-affinity binding of interferon-gamma to a basement membrane complex (matrigel).Journal of Clinical Investigation, 1991
- Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces.Gut, 1989